Sorin strengthens lead business as financial shockwaves recede
This article was originally published in Clinica
Executive Summary
Italian cardiovascular company Sorin has acquired OEM cardiac device firm Oscor’s lead business for $20m. The deal includes Tampa, Florida-based Oscor’s manufacturing facility in the Dominican Republic. Sorin was previously one of Oscor’s OEM clients, with the latter producing its MRI-compatible brady leads. The Italian firm believes the deal will allow further co-development opportunities for similar brady and tachy leads. For its part, Oscor will now focus on its catheters business and custom OEM lead development.